Veterinary Medicines

Heptavac P Plus

Authorised
  • Bibersteinia trehalosi, Inactivated
  • Mannheimia haemolytica, serotype A1, Inactivated
  • Clostridium chauvoei, strain 655, cells and equivalent toxoid
  • Clostridium novyi, toxoid
  • Clostridium tetani, toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, epsilon toxoid
  • Clostridium perfringens, beta toxoid
  • Mannheimia haemolytica, serotype A7, Inactivated
  • Mannheimia haemolytica, serotype A9, Inactivated
  • Mannheimia haemolytica, serotype A6, Inactivated
  • Mannheimia haemolytica, serotype A2, Inactivated
Download as PDF

Product identification

Medicine name:
Heptavac P Plus
Heptavac P
Active substance:
  • Bibersteinia trehalosi, Inactivated
  • Mannheimia haemolytica, serotype A1, Inactivated
  • Clostridium chauvoei, strain 655, cells and equivalent toxoid
  • Clostridium novyi, toxoid
  • Clostridium tetani, toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, epsilon toxoid
  • Clostridium perfringens, beta toxoid
  • Mannheimia haemolytica, serotype A7, Inactivated
  • Mannheimia haemolytica, serotype A9, Inactivated
  • Mannheimia haemolytica, serotype A6, Inactivated
  • Mannheimia haemolytica, serotype A2, Inactivated
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bibersteinia trehalosi, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A1, Inactivated
    500000000.00
    cells
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, strain 655, cells and equivalent toxoid
    0.50
    Protective Dose
    /
    1.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, beta toxoid
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A7, Inactivated
    50000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A9, Inactivated
    50000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A6, Inactivated
    50000.00
    cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A2, Inactivated
    50000.00
    cells
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Low density polyethylene bottle of 500 ml with rubber closure and aluminium cap.
  • Low density polyethylene bottle of 250 ml with rubber closure and aluminium cap.
  • Low density polyethylene bottle of 100 ml with rubber closure and aluminium cap.
  • Low density polyethylene bottle of 50 ml with rubber closure and aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • MSD Animal Health S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 102438
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0136/001
Concerned member states:
  • Greece
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 10/04/2024
Download
Italian (PDF)
Published on: 10/04/2024
Download